FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

40290011000001101: Ledipasvir 33.75mg / Sofosbuvir 150mg granules sachets sugar free (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 22-Dec 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2253241000001116 Ledipasvir 33.75mg / Sofosbuvir 150mg granules sachets sugar free en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2253251000001118 Ledipasvir 33.75mg / Sofosbuvir 150mg granules sachets sugar free (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ledipasvir 33.75mg / Sofosbuvir 150mg granules sachets sugar free Is a Ledipasvir + Sofosbuvir true Inferred relationship Existential restriction modifier
Ledipasvir 33.75mg / Sofosbuvir 150mg granules sachets sugar free Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route granules.oral ontology form and route true Inferred relationship Existential restriction modifier
Ledipasvir 33.75mg / Sofosbuvir 150mg granules sachets sugar free Has specific active ingredient Sofosbuvir true Inferred relationship Existential restriction modifier
Ledipasvir 33.75mg / Sofosbuvir 150mg granules sachets sugar free Has dispensed dose form Granules true Inferred relationship Existential restriction modifier
Ledipasvir 33.75mg / Sofosbuvir 150mg granules sachets sugar free Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Ledipasvir 33.75mg / Sofosbuvir 150mg granules sachets sugar free Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ledipasvir 33.75mg / Sofosbuvir 150mg granules sachets sugar free Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Ledipasvir 33.75mg / Sofosbuvir 150mg granules sachets sugar free Has specific active ingredient Ledipasvir true Inferred relationship Existential restriction modifier
Ledipasvir 33.75mg / Sofosbuvir 150mg granules sachets sugar free VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ledipasvir 33.75mg / Sofosbuvir 150mg granules sachets sugar free VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ledipasvir 33.75mg / Sofosbuvir 150mg granules sachets sugar free Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Ledipasvir 33.75mg / Sofosbuvir 150mg granules sachets sugar free Is a Ledipasvir + Sofosbuvir false Inferred relationship Existential restriction modifier
Ledipasvir 33.75mg / Sofosbuvir 150mg granules sachets sugar free Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Ledipasvir 33.75mg / Sofosbuvir 150mg granules sachets sugar free Plays role Antiviral therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Harvoni 33.75mg/150mg granules sachets (Gilead Sciences Ltd) Is a True Ledipasvir 33.75mg / Sofosbuvir 150mg granules sachets sugar free Inferred relationship Existential restriction modifier
Ledipasvir 33.75mg / Sofosbuvir 150mg granules sachets sugar free 28 sachet Has VMP True Ledipasvir 33.75mg / Sofosbuvir 150mg granules sachets sugar free Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start